Sign in
CompletedNo phase

Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders

Key facts

Who runs it
Institut de Myologie, France
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
1 Dec 2021
Ended
22 Apr 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Lower-limb powered dermoskeleton
Record updated
16 April 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • 18 years and < 70 years of age
  • Height between 1.50 m and 1.95 m
  • Weight between 45 kg and 110 kg
  • Abdominal perimeter < 125 cm
  • Written informed consent
  • Affiliate or beneficiary of a social security scheme
  • Able to comply with all protocol requirements
  • Confirmed diagnosis of a pathology belonging to one of the following family*:; Primary disorders of muscles; Muscular dystrophy; Congenital myopathies; Idiopathic inflammatory myopathy; Mitochondrial myopathies; Metabolic disorders; Inborn errors of metabolism
  • Glycogen storage disease
  • Functional capacities:; Able to stand up from a chair with armrest without other supports at least 3 times and at most 15 times in 30 seconds; Report the ability to walk without the assistance of a person at least 2min; The use of traditional orthoses and walking aids will be accepted excepted knee orthoses and walkers (e.g. canes/crutches, ankle foot orthosis)

Who cannot take part

  • Medical history of osteoporotic fracture
  • Balance disorder with extra neuromuscular causes
  • Severe respiratory insufficiency
  • Unable to participate in the study
  • Inability to comply with protocol requirements
  • Guardianship/trusteeship
  • Pregnant or nursing women
  • Unstable Cardiomyopathy
  • Symptomatic orthostatic hypotension
  • Recent trauma (fall, accident, ...)
  • Unstable Cardiomyopathy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aims of the current study are as follow:

Read full original descriptionShow less

i) Evaluate the safety, usability, and acute efficiency of a programmable ambulation exoskeleton (KeeogoTM Dermoskeleton System, B-Temia Inc., Quebec, Canada) in patients with neuromuscular disorders, ii) Elaborate recommendations regarding usability criteria for safe and efficient use the device in patients with neuromuscular disorders (e.g. type and severity of patient's functional deficits), iii) generate necessary data to foresee a future study involving a home use of the device and assessment of long-term benefits.

The 2 groups in the trial

  • Lower-limb powered dermoskeletonTreatment being tested

    Patients and healthy subjects will use a lower-limb powered dermoskeleton to perform different standardised tasks

  • No assistance deviceNo study treatment, for comparison

    Patients and healthy subjects will perform different standardised tasks without lower-limb powered dermoskeleton

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 April 2026